Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum

23 Mar 2024

Abstract excerpt

This review provides a comprehensive overview of the latest advancements in the clinical utility of liquid biopsy, with a particular focus on epigenetic approaches aimed at overcoming challenges in cancer diagnosis and treatment. It begins by elucidating key epigenetic terms, including methylomics, fragmentomics, and nucleosomics. The review progresses to discuss methods for analyzing circulating cell-free DNA...

Topics

Join the communities discussing this publication.

Cancer Genomics and Diagnostics
Epigenetics and DNA Methylation
Pancreatic and Hepatic Oncology Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38522508
DOI: 10.1016/j.bj.2024.100718

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuumPMID 38522508Read ↗

Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsySemantic proximity Read ↗

Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatmentSemantic proximity Read ↗

Exploring the Role of Circulating Cell-Free DNA in Disease Diagnosis and TherapySemantic proximity Read ↗

Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid BiopsySemantic proximity Read ↗

Comprehensive pan-cancer analysis of cfDNA methylation marks in tumors reveals complex epigenetic regulatory circuits and diagnostic biomarkersSemantic proximity Read ↗

Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in CancerSemantic proximity Read ↗

Bioinformatics Analysis for Circulating Cell-Free DNA in CancerSemantic proximity Read ↗

Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discoverySemantic proximity Read ↗

Cell-Free DNA: Features and Attributes Shaping the Next Frontier in Liquid BiopsySemantic proximity Read ↗

‘Longing’ for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal TestingSemantic proximity Read ↗

Genomics and Epigenomics Approaches for the Quantification of Circulating Tumor DNA in Liquid Biopsy: Relevance of a Multimodal StrategySemantic proximity Read ↗

Clinical applications of cell-free DNA-based liquid biopsy analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.